8/5/2019 9:48 AM
The shares of GlycoMimetics Inc (NASDAQ:GLYC) have more than halved this morning, down 50.1% at $4.56, after Pfizer (PFE), the company's partner in the trial, announced that the biotech's blood diso...
3/6/2018 9:57 AM
Shares GlycoMimetics Inc (NASDAQ:GLYC) are spiraling, after the biotech said the main objective of a late-stage trial for its acute myeloid leukemia is overall survival -- disappointing investors who...
5/18/2017 2:54 PM
Stocks are bouncing back this afternoon, with the Dow sporting a triple-digit gain. Among the names making big moves are Brazil-based oil stock Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR), Brazi...